BioCardia (BCDA) EBT Margin Growth (5y) (2016 - 2024)
Powered by 
Analysis
BioCardia (BCDA) EBT Margin Growth (5y) (2016 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn |
| 10 | BioCardia | 13.06 Mn | 8.94 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | -5.06 Mn |
| Mar 31, 2024 | -242,942.00 |
| Dec 31, 2023 | -1.25 Mn |
| Sep 30, 2023 | 352,227.00 |
| Jun 30, 2023 | -666,724.00 |
| Mar 31, 2023 | -366,528.00 |
| Dec 31, 2022 | 67,583.00 |
| Sep 30, 2022 | 89,430.00 |
| Jun 30, 2022 | 239,374.00 |
| Mar 31, 2022 | -344,573.00 |
| Dec 31, 2021 | -176,588.00 |
| Sep 30, 2021 | 155,245.00 |
| Jun 30, 2021 | -370,987.00 |
| Mar 31, 2021 | -554,739.00 |
| Jun 30, 2018 | -137,371.00 |
| Mar 31, 2018 | -175,331.00 |
| Dec 31, 2017 | -308,300.00 |
| Sep 30, 2017 | -191,138.00 |
| Jun 30, 2017 | -189,118.00 |
| Mar 31, 2017 | -159,927.00 |